Literature DB >> 20934112

Gene expression profiles comparison between 2009 pandemic and seasonal H1N1 influenza viruses in A549 cells.

Xiao-Xing Yang1, Ning Du, Jian-Fang Zhou, Zi Li, Min Wang, Jun-Feng Guo, Da-Yan Wang, Yue-Long Shu.   

Abstract

OBJECTIVE: To perform gene expression profiles comparison so that to identify and understand the potential differences in pathogenesis between the pandemic and seasonal A (H1N1) influenza viruses.
METHODS: A549 cells were infected with A/California/07/09 (H1N1) and A/GuangdongBaoan/51/08 (H1N1) respectively at the same MOI of 2 and collected at 2, 4, 8, and 24 h post infection (p.i.). Gene expression profiles of A549 cells were obtained using the 22 K Human Genome Oligo Array, and differentially expressed genes were analyzed at selected time points.
RESULTS: Microarrays results indicated that both of the viruses suppressed host immune response related pathways including cytokine production while pandemic H1N1 virus displayed weaker suppression of host immune response than seasonal H1N1 virus. Observation on similar anti-apoptotic events such as activation of apoptosis inhibitor and down-regulation of key genes of apoptosis pathways in both infections showed that activities of promoting apoptosis were different in later stage of infection.
CONCLUSIONS: The immuno-suppression and anti-apoptosis events of pandemic H1N1 virus were similar to those seen by seasonal H1N1 virus. The pandemic H1N1 virus had an ability to inhibit biological pathways associated with cytokine responses, NK activation and macrophage recognition.
Copyright © 2010 The Editorial Board of Biomedical and Environmental Sciences. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20934112     DOI: 10.1016/S0895-3988(10)60061-X

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  6 in total

1.  Galectins regulate the inflammatory response in airway epithelial cells exposed to microbial neuraminidase by modulating the expression of SOCS1 and RIG1.

Authors:  Mihai Nita-Lazar; Aditi Banerjee; Chiguang Feng; Gerardo R Vasta
Journal:  Mol Immunol       Date:  2015-09-06       Impact factor: 4.407

2.  Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages.

Authors:  Gustavo Ramírez-Martínez; Alfredo Cruz-Lagunas; Luis Jiménez-Alvarez; Enrique Espinosa; Blanca Ortíz-Quintero; Teresa Santos-Mendoza; María Teresa Herrera; Elsy Canché-Pool; Criselda Mendoza; José L Bañales; Sara A García-Moreno; Juan Morán; Carlos Cabello; Lorena Orozco; Irma Aguilar-Delfín; Alfredo Hidalgo-Miranda; Sandra Romero; Benjamin T Suratt; Moisés Selman; Joaquín Zúñiga
Journal:  Cytokine       Date:  2013-02-21       Impact factor: 3.861

Review 3.  Systems biology unravels interferon responses to respiratory virus infections.

Authors:  Andrea L Kroeker; Kevin M Coombs
Journal:  World J Biol Chem       Date:  2014-02-26

4.  Human Dendritic Cell Response Signatures Distinguish 1918, Pandemic, and Seasonal H1N1 Influenza Viruses.

Authors:  Boris M Hartmann; Juilee Thakar; Randy A Albrecht; Stefan Avey; Elena Zaslavsky; Nada Marjanovic; Maria Chikina; Miguel Fribourg; Fernand Hayot; Mirco Schmolke; Hailong Meng; James Wetmur; Adolfo García-Sastre; Steven H Kleinstein; Stuart C Sealfon
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

5.  Early host responses of seasonal and pandemic influenza A viruses in primary well-differentiated human lung epithelial cells.

Authors:  Rachael L Gerlach; Jeremy V Camp; Yong-Kyu Chu; Colleen B Jonsson
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

6.  The Streptococcus pyogenes fibronectin/tenascin-binding protein PrtF.2 contributes to virulence in an influenza superinfection.

Authors:  Andrea L Herrera; Haddy Faal; Danielle Moss; Leslie Addengast; Lauren Fanta; Kathleen Eyster; Victor C Huber; Michael S Chaussee
Journal:  Sci Rep       Date:  2018-08-14       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.